Valneva COVID-19 vaccine (redirect from VLA2001) withdrawn for commercial reasons at the request Valneva Austria GmbH. "VLA2001 COVID-19 Vaccine". Precision Vaccinations. 31 December 2020. Archived from... 18 KB (1,318 words) - 13:22, 28 March 2024 |
Switzerland Thailand The Netherlands Turkey Ukraine United Kingdom United States VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies... 318 KB (19,351 words) - 20:00, 21 April 2024 |
developed a candidate inactivated whole virus vaccine against COVID-19, VLA2001, derived from its Ixiaro Japanese encephalitis vaccine, which underwent... 12 KB (997 words) - 22:21, 31 December 2023 |
Archived from the original on 9 October 2021. Retrieved 25 August 2021. "VLA2001 COVID-19 Vaccine". Precision Vaccinations. 31 December 2020. Archived from... 192 KB (21,930 words) - 19:29, 15 April 2024 |
FAKHRAVAC, Minhai-Kangtai, QazVac, Sinopharm BIBP, WIBP, Turkovac, and VLA2001. six viral vector vaccines: Sputnik Light, Sputnik V, Oxford–AstraZeneca... 98 KB (20,593 words) - 02:58, 8 March 2024 |
COVID-19 in the UK: The government orders an extra 40 million doses of VLA2001, a vaccine from French biotech company Valneva SE, for availability later... 347 KB (33,588 words) - 08:02, 5 April 2024 |